机译:新加坡C第四次R R Huommatologists关于改性抗风湿剂治疗银屑病关节炎的政府补贴资格的达成声明
Division of RheumatologyNational University Health SystemSingapore Singapore;
Division of RheumatologyNational University Health SystemSingapore Singapore;
Division of RheumatologyNational University Health SystemSingapore Singapore;
Department of MedicineAlexandra Hospital (Jurong Health)Singapore Singapore;
Department of Rheumatology Allergy and ImmunologyTan Tock Seng HospitalSingapore Singapore;
Department of Rheumatology and ImmunologySingapore General HospitalSingapore Singapore;
Division of RheumatologyNational University Health SystemSingapore Singapore;
Koh Wei Howe Arthritis &
Rheumatism Medical ClinicMount Elizabeth Medical CentreSingapore Singapore;
Department of Rheumatology Allergy and ImmunologyTan Tock Seng HospitalSingapore Singapore;
Division of RheumatologyNational University Health SystemSingapore Singapore;
Department of Rheumatology and ImmunologySingapore General HospitalSingapore Singapore;
Department of Rheumatology and ImmunologySingapore General HospitalSingapore Singapore;
Division of RheumatologyNational University Health SystemSingapore Singapore;
Leong Keng Hong Arthritis and Medical ClinicGleneagles Medical CentreSingapore Singapore;
clinical aspects (psoriatic arthritis); drug treatment (psoriatic arthritis); psoriatic arthritis;
机译:新加坡C第四次R R Huommatologists关于改性抗风湿剂治疗银屑病关节炎的政府补贴资格的达成声明
机译:新加坡风湿病学家共识性声明:有资格获得政府补贴的生物风湿性关节炎(RA)改良抗风湿药的生物病政府补助
机译:政府补贴能够改善生物疾病补贴的合伙人,治疗脊柱胸腺炎的抗风湿剂:新加坡经验
机译:关于治疗类风湿性关节炎和其他风湿性疾病的生物制剂的最新共识声明(2002年5月)
机译:关于治疗类风湿性关节炎和其他风湿性疾病的生物制剂的最新共识声明(2002年5月)